John Patrick Shannon Jr.
CIK: 0001553595
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Xeris Biopharma Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Aug 1, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax Payment(F)Direct36.6K shares at avg. $8.08$296K - Jan 31, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax Payment(F)Direct110.8K shares at avg. $7.36$815K - Jan 31, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax Payment(F)Direct111.6K shares at avg. $7.36$822K - Jan 31, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax Payment(F)Direct118.1K shares at avg. $7.36$869K - Jan 30, 2026XERS
Xeris Biopharma Holdings, Inc.
Award(A)Direct478.4K shares- - Jan 5, 2026XERS
Xeris Biopharma Holdings, Inc.
Exercise(M)Direct2.9K shares at avg. $3.94$11K - Jan 5, 2026XERS
Xeris Biopharma Holdings, Inc.
Exercise(M)Direct64.3K shares at avg. $1.55$100K - Jan 5, 2026XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct24.9K shares at avg. $7.08$176K - Jan 5, 2026XERS
Xeris Biopharma Holdings, Inc.
Exercise(M)Direct25.1K shares at avg. $1.55$39K - Nov 14, 2025XERS
Xeris Biopharma Holdings, Inc.
Exercise(M)Direct87.1K shares at avg. $1.55$135K - Nov 13, 2025XERS
Xeris Biopharma Holdings, Inc.
Exercise(M)Direct9K shares at avg. $1.55$14K - Nov 13, 2025XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct23.2K shares at avg. $7.46$173K - Aug 1, 2025XERS
Xeris Biopharma Holdings, Inc.
Tax Payment(F)Direct36.9K shares at avg. $5.38$199K - Jan 31, 2025XERS
Xeris Biopharma Holdings, Inc.
Tax Payment(F)Direct110.8K shares at avg. $3.56$394K - Jan 31, 2025XERS
Xeris Biopharma Holdings, Inc.
Tax Payment(F)Direct110.8K shares at avg. $3.56$394K - Jan 31, 2025XERS
Xeris Biopharma Holdings, Inc.
Award(A)Direct800K shares- - Jan 3, 2025XERS
Xeris Biopharma Holdings, Inc.
Tax Payment(F)Direct39.4K shares at avg. $3.61$142K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment(F) | 36,645 | $8.08 | $296,092 | Direct |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment(F) | 110,750 | $7.36 | $815,120 | Direct |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment(F) | 111,621 | $7.36 | $821,531 | Direct |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment(F) | 118,134 | $7.36 | $869,466 | Direct |
| Jan 30, 2026 | XERS Xeris Biopharma Holdings, Inc. | Award(A) | 478,436 | - | $0 | Direct |
| Jan 5, 2026 | XERS Xeris Biopharma Holdings, Inc. | Exercise(M) | 2,900 | $3.94 | $11,426 | Direct |
| Jan 5, 2026 | XERS Xeris Biopharma Holdings, Inc. | Exercise(M) | 64,265 | $1.55 | $99,611 | Direct |
| Jan 5, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 24,907 | $7.08 | $176,257 | Direct |
| Jan 5, 2026 | XERS Xeris Biopharma Holdings, Inc. | Exercise(M) | 25,136 | $1.55 | $38,961 | Direct |
| Nov 14, 2025 | XERS Xeris Biopharma Holdings, Inc. | Exercise(M) | 87,100 | $1.55 | $135,005 | Direct |
| Nov 13, 2025 | XERS Xeris Biopharma Holdings, Inc. | Exercise(M) | 8,970 | $1.55 | $13,904 | Direct |
| Nov 13, 2025 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 23,242 | $7.46 | $173,402 | Direct |
| Aug 1, 2025 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment(F) | 36,918 | $5.38 | $198,619 | Direct |
| Jan 31, 2025 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment(F) | 110,750 | $3.56 | $394,270 | Direct |
| Jan 31, 2025 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment(F) | 110,750 | $3.56 | $394,270 | Direct |
| Jan 31, 2025 | XERS Xeris Biopharma Holdings, Inc. | Award(A) | 800,000 | - | - | Direct |
| Jan 3, 2025 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment(F) | 39,443 | $3.61 | $142,389 | Direct |
1-17 of 17 transactions
About Shannon John Patrick Jr
Shannon John Patrick Jr (SEC CIK 0001553595) files insider reports with the SEC as Director of Xeris Biopharma Holdings, Inc. (XERS).
Signal8 holds 7 ownership filings by Shannon John Patrick Jr, all Form 4s, filed between Jan 7, 2025 and Aug 21, 2026. Those filings report 17 transactions, from Jan 3, 2025 to Aug 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Shannon John Patrick Jr's filings is in CHICAGO, IL.
Recent filings by Shannon John Patrick Jr
- Aug 1, 2026: Tax withholding of XERS shares (Form 4, code F).
- Jan 31, 2026: Tax withholdings of XERS shares (3 lines, Form 4, code F).
- Jan 30, 2026: Grant or award of XERS shares (Form 4, code A).
- Jan 5, 2026: Option exercises of XERS shares (2 lines, Form 4, code M).
- Jan 5, 2026: Open-market sale of XERS shares (Form 4, code S).
Other insiders filing for Xeris Biopharma Holdings, Inc. (XERS)
- Pieper Steven
- McCulloch Kevin
- Hecht Beth
- KREHER NERISSA, Director
- Kong Garheng, Director
- PERSKY MARLA, Director